A thoughtful approach to hormone care through perimenopause, menopause and beyond. Every plan is shaped around your symptoms, health history and personal priorities with clear guidance and continued provider support.
Hormone replacement therapy may be considered for women experiencing bothersome symptoms related to perimenopause or menopause. At Solaié, every recommendation begins with a detailed conversation about symptoms, medical history, personal risk factors and the type of support being sought.
Your consultation begins with a thoughtful review of menstrual changes, hot flashes, night sweats, sleep, vaginal or urinary concerns, medical history, family history and current medications.
Your provider reviews factors that may influence treatment suitability, including age, time since menopause, uterus status, unexplained bleeding, cardiovascular history, blood-clot risk, liver health and hormone-sensitive conditions.
Systemic therapy may be considered for broader menopausal symptoms, while local vaginal therapy may be selected for specific vaginal or urinary concerns. Women with a uterus generally require a progestogen alongside systemic estrogen to protect the uterine lining.
Your provider will review symptom response, comfort, side effects and changing health needs. The treatment format or dose may be refined through shared decision-making rather than following one fixed pathway.
Women’s hormone therapy may be considered for adults who
Systemic therapy works throughout the body, while local therapy is designed to address specific vaginal or urinary concerns.
Women with a uterus generally need progesterone alongside systemic estrogen. This may not be necessary after a hysterectomy.
Not always. Testing may be recommended when symptoms are unclear or another health condition needs to be considered.
There is no fixed timeline. Treatment is reviewed according to symptoms, response, health history and individual preferences.
